Search results
Carlos G. Grijalva, MD MPH FIDSA. Professor | Division of Pharmacoepidemiology - Health Policy & Biomedical Informatics | Vanderbilt. Verified email at vanderbilt.edu. Pharmacoepidemiology...
Grijalva also serves as the Course Director for Epidemiology I in the Vanderbilt Master of Public Health program, Course Director for PLAN in the School of Medicine, and as Co-PI and Program Director for the new Vanderbilt PROgRESS post-doctoral (T32) training program.
I am a tenured Professor at Vanderbilt University Medical Center in the Division of Pharmacoepidemiology, Departments of Health Policy and Biomedical Informatics.
Dr. Grijalva is a Professor in the Division of Pharmacoepidemiology, Departments of Health Policy and Biomedical Informatics. He has appointments as faculty, scholar and/or investigator at the Vanderbilt Epidemiology Center, the Vanderbilt Center for Health Services Research, the Vanderbilt Institute for Global Health, the Vanderbilt Center for ...
Oct 13, 2015 · Logistic regression was used to calculate odds ratios, comparing the odds of vaccination between influenza-positive (case) and influenza-negative (control) patients with pneumonia, controlling for demographics, comorbidities, season, study site, and timing of disease onset.
- Carlos G. Grijalva, Yuwei Zhu, Derek J. Williams, Wesley H. Self, Krow Ampofo, Andrew T. Pavia, Chri...
- 2015
View Carlos Grijalva’s profile on LinkedIn, a professional community of 1 billion members.
- Vanderbilt University Medical Center
Carlos GRIJALVA, Professor (Full) | Cited by 1,011 | of University of California, Los Angeles, CA (UCLA) | Read 44 publications | Contact Carlos GRIJALVA
